This document discusses compartment modeling in pharmacokinetics. It begins by defining a mathematical model and compartment model. Compartmental models divide the body into compartments and use first-order kinetics to describe the movement of drugs between compartments. Common compartment models include one-compartment open models for intravenous bolus, intravenous infusion, and extravascular administration. Determination of pharmacokinetic parameters like absorption rate, elimination rate constant, and half-life are also covered.
PHARMACOKINETIC MODELS
Drug movement within the body is a complex process. The major objective is therefore to develop a generalized and simple approach to describe, analyse and interpret the data obtained during in vivo drug disposition studies.
The two major approaches in the quantitative study of various kinetic processes of drug disposition in the body are
Model approach, and
Model-independent approach (also called as non-compartmental analysis).
PHARMACOKINETIC MODELS
Drug movement within the body is a complex process. The major objective is therefore to develop a generalized and simple approach to describe, analyse and interpret the data obtained during in vivo drug disposition studies.
The two major approaches in the quantitative study of various kinetic processes of drug disposition in the body are
Model approach, and
Model-independent approach (also called as non-compartmental analysis).
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
The presentation concisely describes the different pharmacokinetic parameters and basics of compartment modelling. It will help undergraduate students to understand the basic concepts of Biopharmaceutics.
United State Pharmacopoeia (USP)The establishment of a rational relationship between a biological property, or a parameter derived from a biological property produced by a dosage form, and a physicochemical property or characteristic of the same dosage form.
Food and Drug Administration (FDA) definitionIVIVC is a predictive mathematical model describing the relationship between an in vitro property of a dosage form and a relevant in vivo response. Generally, the in vitro property is the rate or extent of drug dissolution or release while the in vivo response is the plasma drug concentration or amount of drug absorbed.
1. Measurement of Bioavailability:
Direct and indirect methods may be used to assess drug bioavailability. The in-vivo bioavailability of a drug product is demonstrated by the rate and extent of drug absorption, as determined by comparison of measured parameters, e.g., concentration of the active drug ingredient in the blood, cumulative urinary excretion rates, or pharmacological effects.
For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action.
The design of the bioavailability study depends on the objectives of the study, the ability to analyze the drug (and metabolites) in biological fluids, the pharmacodynamics of the drug substance, the route of drug administration, and the nature of the drug product.
Pharmacokinetic and/or pharmacodynamic parameters as well as clinical observations and in-vitro studies may be used to determine drug bioavailability from a drug product.
1.1. Pharmacokinetic methods:
These are very widely used and based upon the assumption that the pharmacokinetic profile reflects the therapeutic effectiveness of a drug. Thus these are indirect methods. The two major pharmacokinetic methods are:
The major pharmacokinetic methods are:
Plasma / blood level time profile.
o Time for peak plasma (blood) concentration (t max)
o Peak plasma drug concentration (Cmax)
o Area under the plasma drug concentration–time curve (AUC)
Urinary excretion studies.
o Cumulative amount of drug excreted in the urine (Du)
o Rate of drug excretion in the urine (dDu/dt)
o Time for maximum urinary excretion (t)
C. Other biological fluids
1.2. Pharmacodynamic methods:
IT involves direct measurement of drug effect on a (patho) physiological process as a function of time. Disadvantages of it may be high variability, difficult to measure, limited choices, less reliable, more subjective, drug response influenced by several physiological & environmental factors.
They involve determination of bioavailability from:
Acute pharmacological response.
Therapeutic response.
1.3. In-vitro dissolution studies
Closed compartment apparatus
Open compartment apparatus
Dialysis systems.
1.4. Clinical observations
Well-controlled clinical trials
KINETICS OF MULTIPLE DOSING under the Unit Multicompartment Models According to New PCI syllabus 2017 by Ms. Preeti Patil-Vibhute, Assistant Professor, Sarojini College of Pharmacy, Kolhapur.
Pharmacokinetic concepts and principles in humans in order to design individualized dosage regimens which optimize the therapeutic response of a medication while minimizing the chance of an adverse drug reaction.
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...http://neigrihms.gov.in/
A power point presentation on general aspects of Pharmacokinetics suitable for undergraduate medical students beginning to study Pharmacology. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
Biopharmaceutics: Mechanisms of Drug AbsorptionSURYAKANTVERMA2
Biopharmaceutics is defined as the study of factors influencing the rate and amount of drug that reaches the systemic circulation and the use of this information to optimise the therapeutic efficacy of the drug products.
The presentation concisely describes the different pharmacokinetic parameters and basics of compartment modelling. It will help undergraduate students to understand the basic concepts of Biopharmaceutics.
United State Pharmacopoeia (USP)The establishment of a rational relationship between a biological property, or a parameter derived from a biological property produced by a dosage form, and a physicochemical property or characteristic of the same dosage form.
Food and Drug Administration (FDA) definitionIVIVC is a predictive mathematical model describing the relationship between an in vitro property of a dosage form and a relevant in vivo response. Generally, the in vitro property is the rate or extent of drug dissolution or release while the in vivo response is the plasma drug concentration or amount of drug absorbed.
1. Measurement of Bioavailability:
Direct and indirect methods may be used to assess drug bioavailability. The in-vivo bioavailability of a drug product is demonstrated by the rate and extent of drug absorption, as determined by comparison of measured parameters, e.g., concentration of the active drug ingredient in the blood, cumulative urinary excretion rates, or pharmacological effects.
For drug products that are not intended to be absorbed into the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action.
The design of the bioavailability study depends on the objectives of the study, the ability to analyze the drug (and metabolites) in biological fluids, the pharmacodynamics of the drug substance, the route of drug administration, and the nature of the drug product.
Pharmacokinetic and/or pharmacodynamic parameters as well as clinical observations and in-vitro studies may be used to determine drug bioavailability from a drug product.
1.1. Pharmacokinetic methods:
These are very widely used and based upon the assumption that the pharmacokinetic profile reflects the therapeutic effectiveness of a drug. Thus these are indirect methods. The two major pharmacokinetic methods are:
The major pharmacokinetic methods are:
Plasma / blood level time profile.
o Time for peak plasma (blood) concentration (t max)
o Peak plasma drug concentration (Cmax)
o Area under the plasma drug concentration–time curve (AUC)
Urinary excretion studies.
o Cumulative amount of drug excreted in the urine (Du)
o Rate of drug excretion in the urine (dDu/dt)
o Time for maximum urinary excretion (t)
C. Other biological fluids
1.2. Pharmacodynamic methods:
IT involves direct measurement of drug effect on a (patho) physiological process as a function of time. Disadvantages of it may be high variability, difficult to measure, limited choices, less reliable, more subjective, drug response influenced by several physiological & environmental factors.
They involve determination of bioavailability from:
Acute pharmacological response.
Therapeutic response.
1.3. In-vitro dissolution studies
Closed compartment apparatus
Open compartment apparatus
Dialysis systems.
1.4. Clinical observations
Well-controlled clinical trials
KINETICS OF MULTIPLE DOSING under the Unit Multicompartment Models According to New PCI syllabus 2017 by Ms. Preeti Patil-Vibhute, Assistant Professor, Sarojini College of Pharmacy, Kolhapur.
Pharmacokinetic concepts and principles in humans in order to design individualized dosage regimens which optimize the therapeutic response of a medication while minimizing the chance of an adverse drug reaction.
Pharmacokinetics - drug absorption, drug distribution, drug metabolism, drug ...http://neigrihms.gov.in/
A power point presentation on general aspects of Pharmacokinetics suitable for undergraduate medical students beginning to study Pharmacology. Also suitable for Post Graduate students of Pharmacology and Pharmaceutical Sciences.
Process Validation is Key important factor for the Pharmaceutical Industry to maintain Consistent Quality in product which claimed by the manufacturer.
Clinical pharmacokinetic studies are performed to examine the absorption, distribution, metabolism, and excretion of a drug under investigation in healthy volunteers and/or patients
INTRODUCTION TO PHARMACOKINETIC MODELS, ONE COMPARTMENT OPEN MODEL IV BOLUS, IV INFUSION, EXTRAVASCULAR ADMINISTRATION, WAGNER NELSON METHOD, METHOD OF RESIDUALS
This presentation will give the students a basic knowledge about the pharmacokinetics of durgs. It will help them clear the basics before digging deep into the topic.
This presentation quotes various pharmaceutical calculations with examples. The following aspects like percentage calculations, alcoholic dilutions, Alligation method, proof spirit calculations, isotonicity adjustment, posology, temperature measurements, dialysis clearance, Pharmacokinetics calculations were covered with examples.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Compartment Modelling
1. COMPARTMENT
MODELLING
Presented by
T. Joseph Kumar Reddy
11AB1R0097
UNDER THE GUIDANCE OF
Mrs.PALLAVI.K M.pharm
Assistant professor
Department of pharmaceutics
VIGNAN PHARMACY COLLEGE
Vadlamudi, Guntur-522213.
1
2. Contents
What is mathematical model?
What is compartment model?
Classification of pharmacokinetic models.
Classification of compartment models.
One compartment open model.
Two compartment open model.
References. 2
3. MATHEMATICAL MODEL
A model is a mathematical description of biologic system
and used to express quantitative relationships.
Mathematical models are a collection of mathematical
quantities,operations and relations together with their
definitions and they must be realistic and practical.
A model is a hypothesis that employs mathematical
terms to concisely describe quantitative relationships.
3
4. QUALITIES OF A MATHEMATICAL MODEL
Validity: It should have practical applicability and should be
valuable in describing events chosen accurately with high
precision.
Prediction ability: These models predict the qualitative and
quantitative changes in these parameters that are rate
constants and half lives of drugs.
Computability:
Consistency of results: Reproducibility is an important
quality of a mathematical model.
4
5. APPLICATIONS OF PHARMACOKINETIC
MODELS
Characterizing the behavior of drugs in patients.
Calculating the optimum dosage regimens for individual patients.
Evaluating the bioequivalence between different formulations of
same drug.
Determining the influence of altered physiology or disease state on
drug ADME.
Explaining the drug interactions. 5
6. TYPES OF PHARMACOKINETIC MODELS
There are three different types of pharmacokinetic
models they are:
Pharmacokinetic
models
Compartmental
models
Physiological
models
Non
compartmental
analysis
6
7. COMPARTMENTAL MODELS
A compartment is a group of tissues with similar blood
flow and drug afinity. A compartment is physiologic or
anatomic region.
Compartment is the traditional and most widely used
approach to pharmacokinetic characterization of drug.
These models simply interpolate the experimental data
and allow on emperical formula to estimate drug
concentration with time.
7
8. ASSUMPTIONS OF COMPARTMENTAL MODELS
The body is represented as a series of compartment
arranged in series or parallel to each other.
The rate of drug movement between compartment is
described by first order kinetics.
Rate constants are used to represent rate of entry into and
exit from compartment.
A statistical analysis of plasma concentration time data is
another method used to find out no.of compartments.
9. APPLICATIONS OF COMPARTMENT MODELING
It is a simple and flexible approach and is widely used.
It gives a visual representation of various rate processes
involved in drug disposition.
It is useful in predicting drug concentration time profile in
both normal and pathological conditions.
It is useful in relating plasma drug levels in therapeutic and
toxic effects in body.
Its simplicity allows for easy tabulation of Vd,t1/2 etc.
9
10. TYPES OF COMPARTMENT MODELS
Based on whether the compartment is arranged in parallel or
series the compartmental models are classified into four types
they are:
1. Mammillary model.
2. Catenary model.
3. Open model.
4. Closed model.
10
11. MAMMILLARY MODEL
This is the most common compartment used in pharmacokinetics.
The model consists of one or more peripheral compartments
connected to a central compartment.
The central compartment consists of plasma and highly perfused
tissues in which drug distributes rapidly.
The no.of rate constants which will appear in a particular
compartment model is given by R.
For intravenous administration R=2n-1.
For extravascular administration R=2n.
where n=no.of compartments.
11
12. DEPICTION OF VARIOUS MODELS:
Model 1: one compartment open model i.v injection
1
푙표푔푐 = 푙표푔푐0 −
푘퐸푡
2.303
.
Model 2: one compartment open model with first order absorption.
Ka K
1
퐶 = 퐾푎퐹푋0/푉푑(퐾푎 − 퐾푒)[푒−푘푒푡 −푒−퐾푎푡]
12
13. Two compartment open model i.v injection.
K12
K21
K13
푐 = 푅표/푉푐퐾퐸(1 + (퐾퐸 − 훽
2
훽−훼)푒−α푡+(KE-α/α─β)푒−훽푡).
o Two compartment open model with first order absorption.
Ka K12
K21
퐾13
1
1 2
13
14. CATENARY MODEL
In this model compartments are joined to one another in a series like
compartments.
This model is directly linked to blood and this model is rarely used.
Ka K12 K13
1 2 3
K10 K21 K31
14
16. ONE COMPARTMENT OPEN MODEL
The time course of drug concentration determined after the
administration can be satisfactorily explained by assuming the
body as single well mixed compartment with first order
disposition process.
The body is constituted as a single kinetically homogenous
unit that has no barriers to movement of drug.
Elimination is a first order process with first order rate
constant.
Drugs move dynamically in and out of the compartment then
rate of input is greater than rate of output.
16
17. The term OPEN indicates that input and output are unidirectional
and that the drug can be eliminated from body.
metabolism
Blood and
other body
tissues
Ka Ka KE
drug Excretion
output
One compartment open model is generally used to describe plasma
levels following administration of a single dose.
17
18. CLASSIFICATION OF ONE COMPARTMENT
OPEN MODEL(INSTANTANEOUS DISTRIBUTION DATA)
Depending upon rate of input several one compartment models are
defined:
One compartment open model- intravenous bolus administration.
One compartment open model- continuous intravenous infusion.
One compartment open model- extravascular zero order absorption.
One compartment open model- extravascular first order absorption.
18
19. INTRAVENOUS BOLUS ADMINISTRATION
When a drug that distributes rapidly in the body is given in the
form of a rapid intravenous injection, it takes about one or
three minutes for complete circulation.
The model can be diagrammatically depicted as
K1
Blood and
other body
tissues
It can be mathematically represented as
19
20. The rate of drug presentation in body is expressed as
푑푥
= availability- Elimination
푑푡
In bolus injection absorption of drug is absent so availability is zero then
the equation is depicted as
푑푥
푑푡
= -KEX
After applying integrations to the above it can be written as
푥 = 푥표푒−푘푡
Transforming the above equation
푙표푔푥 = 푙표푔푥0 −
퐾퐸푡
2.303
20
21. ESTIMATION OF PHARMACOKINETIC
PARAMETERS BY I.V BOLUS
From i.v bolus the elimination phase can be characterized by
three parameters they are:
Elimination rate constant.
Elimination half life.
Clearance.
Elimination Rate Constant It can be expressed as
푙표푔푐 = 푙표푔푐0 −
퐾퐸푡
2.303
21
22. A graph is plotted by taking log concentration versus time it gives
a straight line and slope gives the elimination rate constant i.e.
−퐾퐸
2.303
= slope
22
23. The elimination rate constant is an additive property and they
are said to be overall elimination constants
퐾퐸 = 퐾푒 + 퐾푚 + 퐾푏 + 퐾1------------
The units of elimination rate constant are 푚푖푛−1.
Elimination half life can be also be called as biological half
life. It can be defined as the time taken for the amount of drug
in body to decline by one half or 50% of its initial volume. It
can be depicted as t1
2
.
t1
2
0.693
퐾
=
23
24. Clearance:
It is the most important parameter in drug clinical drug
applications and is useful in evaluating the mechanism by which a
drug is eliminated.
Clearance is a parameter that relates plasma drug concentration
with rate of drug elimination from below equation
푐푙푒푎푟푎푛푐푒 =
푟푎푡푒 표푓 푒푙푖푚푖푛푎푡푖표푛
푝푙푎푠푚푎 푑푟푢푔 푐표푛푐푒푛푡푟푎푡푖표푛
푐푙푒푎푟푎푛푐푒 =
푑푥/푑푡
푐
The clearance is expressed as ml/min or lit/hr.
24
25. INTRAVENOUS INFUSION
Rapid i.v injection is unsuitable when the drug has the
potency to precipitate toxicity.
Advantages
Ease of control of rate of infusion to fit individual patient
needs.
Prevents fluctuating maxima and minima plasma levels. It is
especially when a drug has narrow therapeutic index.
In critically ill patients the drugs that administered by
infusions such as electrolytes and nutrients.
25
26. The model can be diagrammatically depicted as
Drug Ka KE Elimination
zero order
absorption
Blood and
other body
tissues
In an infusion the rate of change in amount of drug in a body is
the difference between zero orderrate of infusion R0 and first order
elimination –KEX.
푑푥
푑푡
= R0 − KEX
Applying proper integration the above can be written as
26
27. 푐 =
푅0
푐푙푇
(1-푒−퐾퐸푡)
The concentration of drug in plasma approaches a constant value
called as steady state plateau or infusion equilibrium.
27
28. Transforming the above equation in concentration terms
퐶푠푠 =
푅표
퐾퐸 푉푑
=
푅푂
퐶푙푇
or
푖푛푓푢푠푖표푛 푟푎푡푒
푐푙푒푎푟푎푛푐푒
substituting in above equation
퐶 = 퐶푠푠(1 − 푒−퐾퐸푡)
Transforming into log form the equation becomes
퐶푠푠−퐶
퐶푠푠
log(
)=
−퐾퐸푡
2.303
퐶푠푠−퐶
퐶푠푠
log(
)
28
29. The time to reach steady state concentration is dependent upon
elimination half life and infusion rate.
If n is the no.of half lives passed since start of infusion can be
written as
퐶 = 퐶푠푠(1 − (1
2)n )
For therapeutic response more than 90% of steady state
concentration in blood desired which reached 3.3 half lives.
It takes 6.6 half lives for concentration to reach 99% of steady
state.
Shorter the half life sooner is the steady state concentration
reached. 29
30. EXTRAVASCULAR ADMINISTATION
When a drug is administered by extravascular absorption is an
essential for its therapeutic activity and efficacy.
The rate of absorption can be mathematically depicted by two
processes they are:
1. Zero order absorption process.
2. First order absorption process.
30
31. ZERO ORDER ABSORPTION MODEL
It is similar to that of constant rate of infusion.
Ro KE Elimination
Drug at e.v.site
zero order
absorption
The rate of drug absorption incase of several controlled drug
delivery systems.
Blood and
other body
tissues
31
32. FIRST ORDER ABSORPTION MODEL
When ever the drug enters into body it follows first order absorption process
according to one compartment kinetics.
The model can be represented as
Ka KE Elimination
Drug at e.v.site
first order absorption
The differential form of above equation can be
푑푥
푑푡
=퐾푎푋푎 − 퐾푒푋
Blood and
other body
tissues
32
33. Integrating the above equation
푋 =
퐾푎퐹푋0
퐾푎−퐾퐸
[푒−퐾퐸푡-푒−퐾푎푡]
Transforming into c terms as X= VdC
푐 =
퐾푎퐹푋0
퐾푎−퐾퐸 푉푑
[푒−퐾퐸푡-푒−퐾푎푡]
F=Fraction of drug absorbed systematically after
e.v.administration
Here from the i.v infusion studies the tmax and cmax cam be
calculated
tmax=
2.303log(
퐾푎
퐾푒
)
퐾푎−퐾푒
EV absorption study can
퐹푋0
푉푑
Cmax =
푒−퐾푒푡푚푎푥 33
34. DETERMINATION OF ABSORPTION RATE
It is the most important pharmacokinetic parameter when a drug
follows first order absorption. It can be calculated by two methods
in one compartment open model they are:
Absorption rate
constant
determination
Method of residuals
Wagner nelson
method
34
35. METHOD OF RESIDUALS
This method also called as feathering, peeling and stripping.
For a drug that follows one compartment and it is a
biexponential equation.
퐶 =
퐾푎퐹푋0
푉푑(퐾푎−퐾퐸)
[푒−퐾퐸푡 − 푒−퐾푎푡]
퐶 = 퐴푒−퐾퐸푡 − A푒−퐾푎푡
퐶
= 퐴푒−퐾퐸푡 푙표푔퐶 = 푙표푔퐴 −
−퐾퐸푡
2.303
35
37. Subtraction of true values to extrapolated concentration that is
residual concentration.
퐶푟 = 퐴푒−퐾푎푡
푙표푔퐶푟=푙표푔퐴 −
−퐾푎푡
2.303
If KE/Ka≥3 the terminal slope eliminates Ka and not KE. The
slope of residual lines gives KE and not Ka.
This is also known as flip-flop kineticsas the slopes of
two lines exchanged their meanings.
37
38. Extrapolated
concentration
(CE)
Original
concentration
( C0)
5.8mg/ml 2.5mg/ml 3.3mg/ml
Residual concentration= CE-C0
Lag time:
Residual
concentration
(CE-C0)
It is defined as the time difference between drug administration
and start of absorption. It is denoted by t0.
This method is best suited for drugs which are rapidly and
completely absorbed and follow one compartment kinetics even
when given i.v.
38
39. WAGNER NELSON METHOD
One of the best alternatives to curve fitting method in the
estimation of Ka is Wagner Nelson method.
This method involves the determination of Kafrom percent
unabsorbed time plots and does not require the assumptions of
zero or first order absorption.
According to this the amount of drug in body is depicted as
푋퐴 = 푋 + 푋퐸 39
40. 푡=푉푑퐶 + 푉푑퐾[퐴푈퐶]0
푋퐴
푡 (1 )
∞=푉푑퐶∞+푉푑퐾[퐴푈퐶]0
푋퐴
∞ (2 )
(1)
(2)
=
푡
푋퐴
∞ =
푋퐴
푉푑퐶+푉푑퐾[퐴푈퐶]0
푡
푉푑퐾[퐴푈퐶]0
∞
=
푡
푋퐴
∞ =
푋퐴
퐶+퐾[퐴푈퐶]0
푡
퐾[퐴푈퐶]0
∞
If the fraction of total amount of drug absorbed = 1
40
41. Amount remaining to be absorbed = 1-
푡
푋퐴
∞ .
푋퐴
Amount remaining to be absorbed = 1-
퐶+퐾[퐴푈퐶]0
푡
퐾[퐴푈퐶]0
∞
% amount remaining to be absorbed= (1-
퐶+퐾[퐴푈퐶]0
푡
퐾[퐴푈퐶]0
∞ ) 100
A graph is plotted by taking log%ARA on Y-axis and time on
X-axis a straight line is obtained from that slope Ka is
determined.
Log%ARA 41
43. It is the best method to describe and determine the excretion and
elimination rate constants.
Advantages
The method is non-invasive and therefore better subject compliance
is assured.
This method is more convenient since it involves the collection of
urine samples in comparison to drawing of blood periodically.
When coupled with plasma level time data it can also be use to
estimate renal clearance of unchanged drug according to the formula
푐푙푅 =
푡표푡푎푙 푎푚표푢푛푡 표푓 푑푟푢푔 푒푥푐푟푒푡푒푑 푢푛푐ℎ푎푛푔푒푑
푎푟푒푎 푢푛푑푒푟 푝푙푎푠푚푎 푙푒푣푒푙 푡푖푚푒 푐푢푟푣푒
43
44. Estimation of excretion rate constant:
Excretion rate
constant
determination
Excretion rate
method
Sigma minus
method
44
45. EXCRETION RATE METHOD
The appearance of drug in urine can be mathematically depicted
as
푑푥푢
푑푡
= KEX
푑푥푢
푑푡
= kEX0푒−푘푡 (X=X0푒−푘푡)
푙표푔
푑푥푢
푑푡
= 푙표푔kEX0-
푘푡
2.303
In this both the elimination and excretion rates are determined.
The main disadvantage is that the rate of excretion is not
constant and the values are scattered.
45
46. SIGMA MINUS METHOD
The appearance of drug in body can be represented as
푑푥푢
푑푡
=퐾퐸푋
푑푥푢
푑푡
= kEX0푒−푘푡 integrate on both sides
푥푢 = 푥푢∞ 1 − 푒−푘푡
Applying log on both sides
푙표푔 푥푢
∞ − 푥푢 =푙표푔푥푢
∞ −
푘푡
2.303
The main disadvantage is the total urine collected has to be carried
out until no unchanged drug can be detected in urine up to 7 half
lives which may be tedious for drugs having long t1/2.
46
48. It is common in all multi compartment models.
It consists of central compartment i.e., compartment 1
comprising of blood and highly perfused tissues and
peripheral compartment i.e., compartment 2 comprising of
poorly perfused tissues such as skin and adipose tissues.
INTRAVENOUS BOLUS:
K12
1 2
K21
KE
The model can be mathematically represented as
48
50. EXTRAVASCULAR ADMINISTRATION
In two compartment open model for extravascular
administration it can be depicted as
Ka K12
K21
KE
Central
compartment
Peripheral
compartment
퐶 = 푁푒−퐾푎푡 + L푒−훼푡 + M푒−훽푡
The absorption rate is calculated by Loo-Regeilmann method. 50
52. A graph is plotted by taking log %ARA on y-axis and time on
x-axis a straight line is obtained and slope of that gives
absorption rate i.e., slope=
−퐾푎
2.303
.
52
53. CONCLUSION
Compartment model provides a framework for the study of
the dynamic flow of chemicals (nutrients, hormones, drugs,
radio-isotopes, etc.) between different organs which are
assumed as compartments in the human body.
Multi-compartment models have applications in many fields
including pharmacokinetics, epidemiology, biomedicine,
systems theory, complexity theory, engineering, physics,
information science and social science.
53
54. REFERENCES
Comprehensive pharmacy review by Leon shargel
pg.no.113-129.
Bio pharmaceutics and pharmacokinetics by D,M.Brahmankar
and Sunil.B.Jaiswal, Vallabh prakash publications pg.no.245-
299.
The Pearson book to GPAT by Ashok.H.Akabari and Anil
Kumar Baser pg.no.1.114-1.120.
Bio pharmaceutics and pharmacokinetics by venkateswarlu
second edition pg.no.176-182. 54
55. ACKNOWLEDGEMENT
I would like to thank my project guide
Mrs.PALLAVI.K for encouraging me with
positive spirit.
I wish to express my gratitude to our
principal Dr.P.Srinivasa Babu and the
seminar committee. 55